#LEL lithium energy limited
Cash backing of 65c plus asset whilst the share price sitting around 36c. Doesnt make sense.
How about return 20c capital back to shareholder.
Our lead asset DMX-200 has received ODD in Japan for #FSGS, adding to existing designations in the US & Europe. This milestone strengthens $DXB's global strategy to deliver one of the first approved therapies for this rare kidney disease. Read more: https://t.co/Opw989SuAx
$BUB #BUB
Cashflow positive. FDA approval planned for end of the year.
Plenty of cash and huge market in America.
China market can be improved.
Weekly chart, tradung range 14c to 18c for now.
$M7T #M7T
Marketcap $70m
Annual revenue in mid 30m with cashflow positive.
More than 20m in cash. Fresh new board.
Pretty much undervalue at 29c. Can easily up 50c in 6 months.
We are pleased to share an article from Bioshares, featuring insights from our CEO Dr Nina Webster and other biotech leaders on the art of dealmaking, as discussed in a panel at the recent 19th @Bioshares Biotech Summit. Read the full article here.
$DXB #biotech#dealmaking
Asx lithium stocks $PLS $LTR $MIN $IGO go against future price.
Is this a trap or the entire sector trending up regardless if they are making money or not? 😅
$GLN Galan Lithium - We're excited to confirm a $20M placement completed!
• 🌟 $20M placement with Clean Elements Fund satisfied all conditions.
• 🚀 First lithium production planned in H1 2026.
Stay tuned for more updates! https://t.co/FSZlmqEXXJ #Lithium#Investment
$PLS
"BlueOval SK in Hardin County has begun producing batteries at its Kentucky 1 facility, the company announced Aug. 19,"
The main source of lithium is from Posco which currently partnership with $pls